{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:44:07Z","timestamp":1790484247475,"version":"4.1.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.597878","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T01:03:05Z","timestamp":1605229385000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma"],"prefix":"10.3389","volume":"11","author":[{"given":"Irina","family":"Chifu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Heinze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmina T.","family":"Fuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Kroiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kircher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina L.","family":"Ronchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Altieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schirbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fassnacht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Hahner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00379","article-title":"Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy","volume":"10","author":"Mollica Poeta","year":"2019","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.49","article-title":"Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy","volume":"17","author":"Nagarsheth","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000001435","article-title":"Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer Patients","volume":"42","author":"Bluemel","year":"2017","journal-title":"Clin Nucl Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19945","article-title":"Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using (64)Cu-plerixafor PET","volume":"8","author":"Weiss","year":"2017","journal-title":"Oncotarget"},{"key":"B5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/B978-0-12-411638-2.00002-1","article-title":"The intricate role of CXCR4 in cancer","volume":"124","author":"Chatterjee","year":"2014","journal-title":"Adv Cancer Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-010-9256-x","article-title":"CXCL12 \/ CXCR4 \/ CXCR7 chemokine axis and cancer progression","volume":"29","author":"Sun","year":"2010","journal-title":"Cancer Metastasis Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1242\/dev.101071","article-title":"Chemokine signaling in development and disease","volume":"141","author":"Wang","year":"2014","journal-title":"Development"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3217","article-title":"CXCR4 over-expression and survival in cancer: a system review and meta-analysis","volume":"6","author":"Zhao","year":"2015","journal-title":"Oncotarget"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2012.05.005","article-title":"A review on CXCR4\/CXCL12 axis in oncology: No place to hide","volume":"49","author":"Domanska","year":"2013","journal-title":"Eur J Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/cmi.2017.107","article-title":"The unique structural and functional features of CXCL12","volume":"15","author":"Janssens","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.molmed.2012.10.004","article-title":"CXCR7 impact on CXCL12 biology and disease","volume":"19","author":"Sanchez-Martin","year":"2013","journal-title":"Trends Mol Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.17179\/excli2014-585","article-title":"Homing in hematopoietic stem cells: focus on regulatory role of CXCR7 on SDF1a\/CXCR4 axis","volume":"15","author":"Asri","year":"2016","journal-title":"EXCLI J"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009175","article-title":"CXCR7 functions as a scavenger for CXCL12 and CXCL11","volume":"5","author":"Naumann","year":"2010","journal-title":"PloS One"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S36109","article-title":"Emerging targets in cancer management: role of the CXCL12\/CXCR4 axis","volume":"6","author":"Cojoc","year":"2013","journal-title":"Onco Targets Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03018","article-title":"Potential Role of CXCR4 Targeting in the Context of Radiotherapy and Immunotherapy of Cancer","volume":"9","author":"Eckert","year":"2018","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-14-0914","article-title":"Molecular Pathways: Targeting the CXCR4-CXCL12 Axis\u2013Untapped Potential in the Tumor Microenvironment","volume":"21","author":"Scala","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3109\/09553002.2014.906766","article-title":"CXCR4 as Biomarker for Radioresistant Cancer Stem Cells","volume":"90","author":"Trautmann","year":"2014","journal-title":"Int J Radiat Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-2686","article-title":"A phase I trial of LY2510924, a CXCR4 peptide antagonist, in patients with advanced cancer","volume":"20","author":"Galsky","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-162123","article-title":"Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100","volume":"113","author":"Nervi","year":"2009","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-383406","article-title":"A phase 1\/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia","volume":"119","author":"Uy","year":"2012","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-018-1290-8","article-title":"CXCR4-directed theranostics in oncology and inflammation","volume":"32","author":"Kircher","year":"2018","journal-title":"Ann Nucl Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.098798","article-title":"PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent","volume":"52","author":"Gourni","year":"2011","journal-title":"J Nucl Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1021\/jm2009716","article-title":"Design, synthesis, and functionalization of dimeric peptides targeting chemokine receptor CXCR4","volume":"54","author":"Demmer","year":"2011","journal-title":"J Med Chem"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201100320","article-title":"PET imaging of CXCR4 receptors in cancer by a new optimized ligand","volume":"6","author":"Demmer","year":"2011","journal-title":"ChemMedChem"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2310\/7290.2014.00041","article-title":"Positron emission tomographic imaging of CXCR4 in cancer: challenges and promises","volume":"13","author":"George","year":"2014","journal-title":"Mol Imaging"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2040206619829382","DOI":"10.1177\/2040206619829382","article-title":"Mozobil\u00ae (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration","volume":"27","author":"De Clercq","year":"2019","journal-title":"Antivir Chem Chemother"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3892\/IJO_00000172","article-title":"Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer","volume":"34","author":"Lee","year":"2009","journal-title":"Int J Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/891020","article-title":"Immunohistochemical expression of CXCR4 on breast cancer and its clinical significance","volume":"2015","author":"Okuyama Kishima","year":"2015","journal-title":"Anal Cell Pathol (Amst)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/1479-5876-11-238","article-title":"CXCR7 expression in esophageal cancer","volume":"11","author":"Tachezy","year":"2013","journal-title":"J Transl Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4132\/jptm.2018.09.19","article-title":"High Cytoplasmic CXCR4 Expression Predicts Prolonged Survival in Triple-Negative Breast Cancer Patients Treated with Adjuvant Chemotherapy","volume":"52","author":"Shim","year":"2018","journal-title":"J Pathol Transl Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2009.07.015","article-title":"Expression of the chemokine receptor CXCR4 correlates with a favorable prognosis in patients with adenocarcinoma of the lung","volume":"68","author":"Minamiya","year":"2009","journal-title":"Lung Cancer (Amsterdam Netherlands)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-8-340","article-title":"Cytoplasmic CXCR4 expression in breast cancer: induction by nitric oxide and correlation with lymph node metastasis and poor prognosis","volume":"8","author":"Yasuoka","year":"2008","journal-title":"BMC Cancer"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24030","article-title":"Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification","volume":"115","author":"Fassnacht","year":"2009","journal-title":"Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14067","article-title":"Livin\/BIRC7 expression as malignancy marker in adrenocortical tumors","volume":"8","author":"Altieri","year":"2017","journal-title":"Oncotarget"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1530\/erc-15-0163","article-title":"Notch1 pathway in adrenocortical carcinomas: correlations with clinical outcome","volume":"22","author":"Ronchi","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0788","article-title":"ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas","volume":"178","author":"Valeria","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.364","article-title":"CXCR4\/CXCR7\/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma","volume":"117","author":"Werner","year":"2017","journal-title":"Br J Cancer"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.09975","article-title":"Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma","volume":"71","author":"Heinze","year":"2018","journal-title":"Hypertension"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1814072115","article-title":"Isolation and characterization of adrenocortical progenitors involved in the adaptation to stress","volume":"115","author":"Steenblock","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00052","article-title":"Molecular Mechanisms of Stem\/Progenitor Cell Maintenance in the Adrenal Cortex","volume":"8","author":"Lerario","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3182","article-title":"Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection","volume":"100","author":"Beuschlein","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B42","doi-asserted-by":"publisher","first-page":"SUN","DOI":"10.1210\/js.2019-SUN-335","article-title":"SUN-335 The Chemokine Receptor 4 (CXCR4) Plays an Important Role in Adrenocortical Carcinoma Cell Proliferation","volume":"3","author":"Kitawaki","year":"2019","journal-title":"J Endocr Soc"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27665","article-title":"CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice","volume":"61","author":"Chen","year":"2015","journal-title":"Hepatology"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-0081","article-title":"Mobilization of CD8(+) T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer","volume":"25","author":"Seo","year":"2019","journal-title":"Clin Cancer Res an Off J Am Assoc Cancer Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1815515116","article-title":"Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer","volume":"116","author":"Chen","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201802067RR","article-title":"Dual blockade of CXCL12-CXCR4 and PD-1-PD-L1 pathways prolongs survival of ovarian tumor-bearing mice by prevention of immunosuppression in the tumor microenvironment","volume":"33","author":"Zeng","year":"2019","journal-title":"FASEB J"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.2174\/0929867324666170830111531","article-title":"Targeting CXCL12\/CXCR4 Axis in Tumor Immunotherapy","volume":"26","author":"Zhou","year":"2019","journal-title":"Curr Med Chem"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The Immune Landscape of Cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6072863","article-title":"Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma","volume":"2019","author":"Fiorentini","year":"2019","journal-title":"J Oncol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1530\/EC-18-0398","article-title":"Immunotherapy failure in adrenocortical cancer: where next","volume":"7","author":"Cosentini","year":"2018","journal-title":"Endocr Connections"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2020.101434","article-title":"Next-generation therapies for adrenocortical carcinoma","volume":"34","author":"Altieri","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000469","article-title":"Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma","volume":"8","author":"Landwehr","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.7150\/thno.19119","article-title":"[(177)Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic Agent","volume":"7","author":"Schottelius","year":"2017","journal-title":"Theranostics"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.7150\/thno.45537","article-title":"A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency","volume":"10","author":"Osl","year":"2020","journal-title":"Theranostics"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.223420","article-title":"Side Effects of CXC-Chemokine Receptor 4-Directed Endoradiotherapy with Pentixather Before Hematopoietic Stem Cell Transplantation","volume":"60","author":"Maurer","year":"2019","journal-title":"J Nucl Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3074","article-title":"Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis","volume":"13","author":"Hernandez","year":"2011","journal-title":"Breast Cancer Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.167932","article-title":"Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3\/CXCR7) in Human Cancer Xenografts","volume":"57","author":"Behnam Azad","year":"2016","journal-title":"J Nucl Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004069","article-title":"Reassessment of CXCR4 chemokine receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-2","volume":"3","author":"Fischer","year":"2008","journal-title":"PloS One"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2020.597878\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T01:03:07Z","timestamp":1605229387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2020.597878\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,13]]},"references-count":58,"alternative-id":["10.3389\/fendo.2020.597878"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.597878","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,13]]},"article-number":"597878"}}